Non-invasive scoring systems of liver fibrosis predict prognosis in the cohort with myocardial infarction

  • 0Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.

|

|

Summary

This summary is machine-generated.

Patients with acute myocardial infarction (AMI) and liver fibrosis face higher long-term mortality risks. Non-invasive liver fibrosis tests like FIB-4 and APRI can help predict survival, regardless of type 2 diabetes mellitus (T2DM) status.

Area Of Science

  • Cardiology
  • Hepatology
  • Diabetology

Background

  • Patients with type 2 diabetes mellitus (T2DM) and liver fibrosis have elevated cardiovascular event risks.
  • The long-term prognosis of liver fibrosis and T2DM following acute myocardial infarction (AMI) requires further investigation.

Purpose Of The Study

  • To compare clinical characteristics and prognosis of AMI patients with T2DM and evidence of liver fibrosis.
  • To evaluate the utility of non-invasive liver fibrosis tests in predicting long-term mortality after AMI.

Main Methods

  • Stratified 3287 AMI patients into low, intermediate, and high-risk groups for fibrosis using Fibrosis-4 Index (FIB-4), Aspartate Aminotransferase to Platelet Ratio Index (APRI), and Non-alcoholic Fatty Liver Disease Fibrosis Score (NFS).
  • Assessed 5-year all-cause mortality using Kaplan-Meier curves and Cox regression analysis, adjusting for confounders.
  • Analyzed mortality prediction based on fibrosis risk scores and T2DM status.

Main Results

  • 1547 patients (47%) were stratified as high-risk by at least one non-invasive test.
  • Higher APRI and NFS scores showed a dose-response relationship with increased mortality risk.
  • High-risk FIB-4 and APRI independently predicted mortality irrespective of T2DM status; NFS predicted mortality only in T2DM patients.
  • Overall, high-risk fibrosis stratification was associated with excess long-term mortality (aHR 1.780, p < 0.001).

Conclusions

  • Non-invasive liver fibrosis tests (FIB-4, APRI, NFS) are valuable tools for risk prognostication in AMI patients.
  • FIB-4 and APRI demonstrate independent predictive value for mortality post-AMI, even in patients without T2DM.
  • Liver fibrosis assessment can enhance long-term mortality risk stratification in AMI survivors, particularly those with T2DM.

Related Concept Videos

Ultrasound II: Endoscopic Ultrasound and FibroScan 01:25

204

Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):

Technological Integration: EUS is a sophisticated integration of optical endoscopy and ultrasonography. The endoscope visualizes the mucosal surface directly, while the ultrasound component penetrates deeper to visualize organs and structures beyond the gastrointestinal wall.
Image Formation: The ultrasound...

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT 01:25

122

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...

Blood Studies for Cardiovascular System I: Cardiac Biomarkers 01:20

341

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...